The most studied and well known mechanism is inhibition of PD-L1 on tumor cells, and the PD-1 and CTLA-4 signaling pathways in T cell cells (Kosanić et al., 2013; Borghaei et al., 2015; Horn et al., 2018). This evidence concerns the gene CTLA4 and neoplasm.